chromium(3+)/Finding
One finding, on its own
A single claim from the graph, with the evidence strength computed from its study, the sentence it was drawn from, and the paper. This address does not change.
chromium(3+) — decreases HOMA-IR
Evidence strength: very limited.Findingreplicated ×2“Results revealed significant reduction in FPG (weighted mean difference (WMD): -19.00 mg/dl, 95% CI: -36.15, -1.85, P = 0.030; I2: 99.8%, p < 0.001), insulin level (WMD: -12.35 pmol/l, 95% CI: -17.86, -6.83, P < 0.001), HbA1C (WMD: -0.71 %, 95% CI: -1.19, -0.23, P = 0.004) and HOMA-IR (WMD: -1.53, 95% CI: -2.35, -0.72, P < 0.001; I2: 89.9%, p < 0.001) after chromium supplementation.”
Quoted verbatim from Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.. - Study
- meta-analysis
- Population
- Patients with type 2 diabetes, pooled randomized controlled trials
Effect -1.53 mean difference, 95% CI -2.35 to -0.72
Effects of chromium supplementation on glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.2020PMID:3273090310.1016/j.phrs.2020.105098Permalink
To cite this finding: https://catalystproject.ai/e/01M5KWMZZY01NQ672MZAQRV39W